2914 On Other Exchanges
Symbol
Exchange
2914 is not on other exchanges.

japan tobacco inc (2914) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for JAPAN TOBACCO INC (2914)
\

Related News

No related news articles were found.

japan tobacco inc (2914) Related Businessweek News

View More BusinessWeek News

japan tobacco inc (2914) Details

Japan Tobacco Inc., together with its subsidiaries, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food business. It sells tobacco products approximately in 130 countries under the Winston, Camel, MEVIUS, and LD brands. The company engages in the research and development, manufacture, and sale of prescription drugs in the fields of metabolic diseases, viral infection, and autoimmune/inflammatory diseases. It manufactures and sells staple food products, including frozen noodles, frozen rice, packed-cooked rice, and frozen baked bread; bakery products; and seasonings, including yeast extracts and oyster sauce. The company was founded in 1898 and is headquartered in Tokyo, Japan.

39,000 Employees
Last Reported Date: 04/3/18
Founded in 1898

japan tobacco inc (2914) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

japan tobacco inc
Japan Tobacco Inc. Announces Preliminary Domestic Cigarette Sales Results for the Month and Year to Date Ended June 2018

Japan Tobacco Inc. announced preliminary domestic cigarette sales results for the month and year to date ended June 2018. For the month, the company reported sales volume of 7.0 billion of cigarettes against 8.0 billion cigarettes a year ago. Japanese domestic cigarette revenue was ¥41.9 billion against ¥47.2 billion a year ago. For the year to date, the company reported sales volume of 40.4 billion of cigarettes against 46.8 billion cigarettes a year ago. Japanese domestic cigarette revenue was ¥241.3 billion against ¥278.5 billion a year ago.

Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. Discontinue Development of NK-1 Receptor Antagonist (JTS-661) and Terminate Exclusive License Agreement with Menlo Therapeutics

Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. have announced that the companies decided to discontinue the development of JTS-661 (serlopitant). Simultaneously, JT and Torii have also announced the termination of the license agreement with Menlo Therapeutics Inc. (Menlo Therapeutics) which was entered into on August 10, 2016 for the development and commercialization of serlopitant in Japan. JTS-661 is a candidate compound of the first-in-class oral drug for the treatment of pruritus as a neurokinin (NK-1) receptor antagonist expected to suppress pruritus involving the NK-1 signalling pathway. JT and Torii decided to discontinue development of JTS-661 and to terminate the license agreement with Menlo Therapeutics, following comprehensive reconsideration of the development plan. The effects of this termination of the exclusive license agreement on the business performance of both JT and Torii's in this fiscal year will be immaterial.

Japan Tobacco Inc. Announces Preliminary Domestic Cigarette Sales Results for the Month and Year to Date Ended May 2018

Japan Tobacco Inc. announced preliminary domestic cigarette sales results for the month and year to date ended May 2018. For the month, the company reported sales volume of 7.1 billion of cigarettes against 8.2 billion cigarettes a year ago. Japanese domestic cigarette revenue was ¥42.8 billion against ¥48.9 billion a year ago. For the year to date, the company reported sales volume of 33.4 billion of cigarettes against 38.9 billion cigarettes a year ago. Japanese domestic cigarette revenue was ¥199.4 billion against ¥231.3 billion a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2914 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2914.
View Industry Companies
 

Industry Analysis

2914

Industry Average

Valuation 2914 Industry Range
Price/Earnings 13.0x
Price/Sales 2.4x
Price/Book 1.9x
Price/Cash Flow 12.0x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact JAPAN TOBACCO INC, please visit www.jt.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.